Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants

NCT00385632 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1224

Last updated 2014-04-21

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of two different anti-HIV drug regimens on quality of life and health care utilization among SMART study participants.

Conditions

  • HIV Infections

Interventions

DRUG

Antiretroviral Regimens

Various antiretroviral therapy combinations already being administered to participants

Sponsors & Collaborators

  • Community Programs for Clinical Research on AIDS

    collaborator NETWORK
  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Wafaa El-Sadr, MD, MPH · Harlem AIDS Treatment Group, Harlem Hospital Center

  • James Neaton, PhD · CPCRA Statistical and Data Management Center/CCBR

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00385632 on ClinicalTrials.gov